nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—Midodrine—CYP2D6—Alzheimer's disease	0.0387	1	CrCbGaD
Methoxamine—ADRA1D—forebrain—Alzheimer's disease	0.0319	0.14	CbGeAlD
Methoxamine—ADRA1D—telencephalon—Alzheimer's disease	0.0294	0.128	CbGeAlD
Methoxamine—ADRA1A—forebrain—Alzheimer's disease	0.0183	0.0802	CbGeAlD
Methoxamine—ADRA1B—nervous system—Alzheimer's disease	0.0177	0.0775	CbGeAlD
Methoxamine—ADRA1D—nervous system—Alzheimer's disease	0.0173	0.0758	CbGeAlD
Methoxamine—ADRA1B—central nervous system—Alzheimer's disease	0.0171	0.0746	CbGeAlD
Methoxamine—ADRA1A—telencephalon—Alzheimer's disease	0.0169	0.0738	CbGeAlD
Methoxamine—ADRA1D—central nervous system—Alzheimer's disease	0.0167	0.073	CbGeAlD
Methoxamine—ADRA1B—brain—Alzheimer's disease	0.0135	0.0592	CbGeAlD
Methoxamine—ADRA1D—brain—Alzheimer's disease	0.0133	0.0579	CbGeAlD
Methoxamine—ADRA1A—nervous system—Alzheimer's disease	0.00996	0.0435	CbGeAlD
Methoxamine—ADRA1A—central nervous system—Alzheimer's disease	0.00959	0.0419	CbGeAlD
Methoxamine—ADRA1A—cerebellum—Alzheimer's disease	0.00937	0.041	CbGeAlD
Methoxamine—ADRA1A—brain—Alzheimer's disease	0.00761	0.0333	CbGeAlD
Methoxamine—ADRA1B—Signaling Pathways—PYY—Alzheimer's disease	0.00103	0.0014	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00102	0.00139	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.00101	0.00138	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CRH—Alzheimer's disease	0.00101	0.00138	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—SST—Alzheimer's disease	0.000997	0.00136	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—GAB2—Alzheimer's disease	0.000997	0.00136	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—APP—Alzheimer's disease	0.000972	0.00133	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CCL2—Alzheimer's disease	0.000957	0.00131	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—NPS—Alzheimer's disease	0.000955	0.0013	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NPY—Alzheimer's disease	0.000949	0.00129	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IAPP—Alzheimer's disease	0.000943	0.00129	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PSENEN—Alzheimer's disease	0.00094	0.00128	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000928	0.00127	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000927	0.00127	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APH1A—Alzheimer's disease	0.000927	0.00126	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000923	0.00126	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000922	0.00126	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000917	0.00125	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CRH—Alzheimer's disease	0.000915	0.00125	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PYY—Alzheimer's disease	0.000914	0.00125	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000911	0.00124	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—SST—Alzheimer's disease	0.000911	0.00124	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000903	0.00123	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NCSTN—Alzheimer's disease	0.000902	0.00123	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000895	0.00122	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDK5—Alzheimer's disease	0.000892	0.00122	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—F2—Alzheimer's disease	0.000892	0.00122	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—APP—Alzheimer's disease	0.000888	0.00121	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LRP1—Alzheimer's disease	0.00088	0.0012	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NPS—Alzheimer's disease	0.000868	0.00118	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000863	0.00118	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GFAP—Alzheimer's disease	0.000859	0.00117	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GAL—Alzheimer's disease	0.000859	0.00117	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR6—Alzheimer's disease	0.000859	0.00117	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000849	0.00116	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NPY—Alzheimer's disease	0.000843	0.00115	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000838	0.00114	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000837	0.00114	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—GAB2—Alzheimer's disease	0.000828	0.00113	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—SST—Alzheimer's disease	0.000828	0.00113	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CRH—Alzheimer's disease	0.000813	0.00111	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—SST—Alzheimer's disease	0.00081	0.00111	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.00081	0.00111	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—APP—Alzheimer's disease	0.000807	0.0011	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CCL2—Alzheimer's disease	0.000795	0.00108	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDK5—Alzheimer's disease	0.000793	0.00108	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—F2—Alzheimer's disease	0.000792	0.00108	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—APP—Alzheimer's disease	0.000789	0.00108	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PSENEN—Alzheimer's disease	0.00078	0.00106	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NPS—Alzheimer's disease	0.000771	0.00105	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APH1A—Alzheimer's disease	0.000769	0.00105	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000767	0.00105	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	0.000763	0.00104	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000761	0.00104	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—A2M—Alzheimer's disease	0.000757	0.00103	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000754	0.00103	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NCSTN—Alzheimer's disease	0.000749	0.00102	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000747	0.00102	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000744	0.00102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000735	0.001	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	0.000735	0.001	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PSEN2—Alzheimer's disease	0.000734	0.001	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	0.00073	0.000997	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	0.000716	0.000978	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	0.000713	0.000974	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	0.000713	0.000974	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000708	0.000966	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	0.000706	0.000964	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000693	0.000946	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000692	0.000945	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	0.000683	0.000933	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000678	0.000926	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000676	0.000923	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NPY—Alzheimer's disease	0.000675	0.000922	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IAPP—Alzheimer's disease	0.000671	0.000916	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000665	0.000908	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CRH—Alzheimer's disease	0.000651	0.000889	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	0.000649	0.000886	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCR5—Alzheimer's disease	0.000643	0.000877	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	0.000634	0.000865	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	0.000634	0.000865	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000629	0.000858	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	0.000629	0.000858	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000626	0.000854	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.00062	0.000846	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NPS—Alzheimer's disease	0.000617	0.000843	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000614	0.000839	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	0.000609	0.000831	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—F2—Alzheimer's disease	0.000607	0.000829	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTK2B—Alzheimer's disease	0.000606	0.000827	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NTRK2—Alzheimer's disease	0.000589	0.000804	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GAB2—Alzheimer's disease	0.000589	0.000804	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SST—Alzheimer's disease	0.000589	0.000804	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000587	0.000802	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CALM1—Alzheimer's disease	0.000587	0.000801	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GSK3A—Alzheimer's disease	0.000584	0.000797	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000575	0.000785	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APP—Alzheimer's disease	0.000574	0.000784	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000563	0.000768	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	0.00056	0.000765	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	0.000558	0.000762	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	0.000557	0.00076	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000556	0.000759	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—F2—Alzheimer's disease	0.000551	0.000753	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000551	0.000751	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLCB1—Alzheimer's disease	0.000542	0.000739	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000541	0.000738	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	0.000541	0.000738	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	0.000533	0.000728	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000522	0.000712	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000522	0.000712	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	0.000512	0.0007	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.00051	0.000697	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00051	0.000696	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NGFR—Alzheimer's disease	0.000505	0.00069	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	0.000504	0.000688	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	0.000503	0.000686	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CREB1—Alzheimer's disease	0.000502	0.000686	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.0005	0.000682	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	0.000498	0.000679	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000495	0.000675	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADAM10—Alzheimer's disease	0.000494	0.000674	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCL2—Alzheimer's disease	0.000491	0.000671	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	0.000489	0.000667	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	0.000489	0.000667	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	0.000489	0.000667	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	0.000487	0.000665	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	0.000485	0.000662	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	0.00048	0.000656	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	0.000476	0.00065	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000474	0.000647	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—S100B—Alzheimer's disease	0.000467	0.000637	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000464	0.000633	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	0.000458	0.000625	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	0.000455	0.000621	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000453	0.000618	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	0.00045	0.000614	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000448	0.000611	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000446	0.000609	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF2—Alzheimer's disease	0.000444	0.000607	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000434	0.000593	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000434	0.000593	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	0.000434	0.000593	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000432	0.00059	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.00043	0.000588	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1R—Alzheimer's disease	0.00043	0.000587	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	0.000423	0.000578	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	0.000419	0.000573	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	0.000417	0.000569	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	0.000412	0.000562	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	0.00041	0.000559	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	0.000408	0.000557	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	0.000408	0.000557	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	0.000406	0.000555	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	0.000401	0.000547	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000399	0.000545	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	0.00039	0.000533	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	0.000387	0.000529	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	0.00038	0.000518	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000373	0.000509	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	0.000371	0.000507	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.00037	0.000505	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	0.000369	0.000504	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000364	0.000497	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000362	0.000495	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	0.000357	0.000487	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	0.000347	0.000473	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	0.000345	0.000471	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	0.000345	0.000471	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	0.000344	0.00047	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	0.000342	0.000467	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	0.000342	0.000467	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	0.000339	0.000463	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	0.000332	0.000454	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	0.00033	0.00045	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000328	0.000447	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	0.000326	0.000445	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	0.000324	0.000442	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000319	0.000435	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000317	0.000432	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	0.000315	0.00043	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	0.000308	0.000421	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	0.000304	0.000415	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000301	0.000411	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	0.000299	0.000408	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	0.000297	0.000405	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000295	0.000403	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	0.000295	0.000403	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	0.00029	0.000396	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	0.000288	0.000393	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	0.000288	0.000393	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	0.000287	0.000391	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	0.000287	0.000391	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	0.000285	0.00039	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	0.000284	0.000388	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	0.00028	0.000382	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000274	0.000374	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	0.000274	0.000374	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	0.00027	0.000369	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000265	0.000361	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	0.000259	0.000353	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	0.000255	0.000349	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	0.000255	0.000348	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	0.000255	0.000348	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	0.000252	0.000344	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	0.000248	0.000339	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	0.000246	0.000336	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	0.000245	0.000334	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	0.000243	0.000332	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	0.000241	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	0.00024	0.000328	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	0.000237	0.000323	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000235	0.000321	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000222	0.000303	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	0.00022	0.000301	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	0.00022	0.0003	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	0.000219	0.000299	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	0.000218	0.000298	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	0.000217	0.000297	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	0.000215	0.000293	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	0.000214	0.000292	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	0.00021	0.000287	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	0.000202	0.000276	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	0.000201	0.000275	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	0.000191	0.00026	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	0.000186	0.000254	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000184	0.000251	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	0.000182	0.000249	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	0.000181	0.000247	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	0.000171	0.000234	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	0.000168	0.000229	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	0.000167	0.000228	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000163	0.000223	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	0.000162	0.000221	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	0.000161	0.00022	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	0.000155	0.000211	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	0.000149	0.000203	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	0.000148	0.000203	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	0.000142	0.000194	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	0.000141	0.000192	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	0.000137	0.000188	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	0.000129	0.000176	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	0.000126	0.000172	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	0.000119	0.000162	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	0.000117	0.00016	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	0.000107	0.000146	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	0.000104	0.000142	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	9.87e-05	0.000135	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	9.5e-05	0.00013	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	8.77e-05	0.00012	CbGpPWpGaD
